Label: THYROVET EQUINE- levothyroxine sodium powder

  • NDC Code(s): 13985-575-01, 13985-575-10
  • Packager: MWI/Vet One
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated November 7, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • VETERINARY INDICATIONS

    A Palatable Supplement for the Correction of Conditions Associated with Hypothyroidism in Horses and Ponies

    For animal use only.


    Keep out of reach of children.


    CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • INDICATIONS:

    For use in horses and ponies for correction of conditions associated with low circulating thyroid hormone (hypothyroidism).

  • DOSAGE:

    Doses should be individualized and animals should be monitored daily for clinical signs of hyperthyroidism or hypersensitivity. Suggested initial doses are 1-10 mg levothyroxine sodium (T4)/100 lb. body weight (2-20 mg/100 kg) once per day or in divided doses. Response to the administration of ThyroVetTM Equine Powder should be evaluated clinically every week until an adequate maintenance dose is established. In most horses, this is usually in the range of 35 to 100 mg total daily dose of T4 (1-3 level tablespoonfuls ThyroVetTM Equine Powder).

  • ACTIVE INGREDIENTS:

    Each pound (453.6 g) contains:
    Levothyroxine Sodium USP ............................. 0.22% (1.0 g)
    One level teaspoon contains .............................. 12 mg of T4
    One level tablespoon contains ............................ 36 mg of T4

  • WARNING:

    Administer with caution to animals with clinically significant heart disease, hypertension, or other complications for which a sharply increased metabolic rate might prove hazardous. Use in pregnant mares has not been evaluated.

  • STORAGE:

    Store at controlled room temperature between 15°- 30°C (59°-86°F). Keep container tightly closed when not in use.

    image of eye clock

  • Net Contents:

    1 lb (453.6 grams) V1 510261

  • INFORMATION FOR OWNERS/CAREGIVERS

    Distributed by: MWI
    Boise, ID 83705
    (888) 694-8381
    www.VetOne.net

    image of made in usa flag

  • 1 lb (453.6 g)

    image of LBMWNS190_r0214

    12 x 1 lb (453.6 g)

    image LBMWNS190B_r0214

  • 10 lb (4.536 kg)

    image of 10 lb label

  • INGREDIENTS AND APPEARANCE
    THYROVET  EQUINE
    levothyroxine sodium powder
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:13985-575
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LEVOTHYROXINE SODIUM (UNII: 9J765S329G) (LEVOTHYROXINE - UNII:Q51BO43MG4) LEVOTHYROXINE SODIUM ANHYDROUS1000 mg  in 453.6 g
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:13985-575-0112 in 1 CASE
    1453.6 g in 1 JAR
    2NDC:13985-575-101 in 1 CASE
    2453600 g in 1 PAIL
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other02/17/2014
    Labeler - MWI/Vet One (019926120)
    Registrant - First Priority Incorporated (179925722)
    Establishment
    NameAddressID/FEIBusiness Operations
    First Priority Incorporated179925722manufacture
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events (Animal Drug), FDA Safety Recalls (Animal Drug)

Related Resources

Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!